Publications

1.

Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.

Ciccarelli O, Barkhof F, Bodini B, Stefano ND, Golay X, Nicolay K, Pelletier D, Pouwels PJ, Smith SA, Wheeler-Kingshott CA, Stankoff B, Yousry T, Miller DH.

Lancet Neurol. 2014 Aug;13 (8) :807-822. Epub 2014 Jul 6. PMID: 25008549

2.

In vivo evidence of glutamate toxicity in multiple sclerosis.

Azevedo CJ, Kornak J, Chu P, Sampat M, Okuda DT, Cree BA, Nelson SJ, Hauser SL, Pelletier D.

Ann Neurol. 2014 Jul 9; Epub 2014 Jul 9. PMID: 25043416

3.

Metric optimization for surface analysis in the laplace-beltrami embedding space.

Shi Y, Lai R, Wang DJ, Pelletier D, Mohr D, Sicotte N, Toga AW.

IEEE Trans Med Imaging. 2014 Jul;33 (7) :1447-63. Epub 2014 Mar 25. PMID: 24686245

4.

Magnetic resonance spectroscopy markers of disease progression in multiple sclerosis.

Llufriu S, Kornak J, Ratiney H, Oh J, Brenneman D, Cree BA, Sampat M, Hauser SL, Nelson SJ, Pelletier D.

JAMA Neurol. 2014 Jul 1;71 (7) :840-7. PMID: 24839987

5.

Atomic force microscope controlled topographical imaging and proximal probe thermal desorption/ionization mass spectrometry imaging.

Ovchinnikova OS, Kjoller K, Hurst GB, Pelletier DA, Van Berkel GJ.

Anal Chem. 2014 Jan 21;86 (2) :1083-90. Epub 2013 Dec 30. PMID: 24377265

6.

Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling.

Gold SM, O'Connor MF, Gill R, Kern KC, Shi Y, Henry RG, Pelletier D, Mohr DC, Sicotte NL.

Hum Brain Mapp. 2014 Jan;35 (1) :30-7. Epub 2012 Jul 30. PMID: 22847919

7.

Radiologically isolated syndrome: 5-year risk for an initial clinical event.

Okuda DT, Siva A, Kantarci O, Inglese M, Katz I, Tutuncu M, Keegan BM, Donlon S, Hua le H, Vidal-Jordana A, Montalban X, Rovira A, Tintoré M, Amato MP, Brochet B, de Seze J, Brassat D, Vermersch P, De Stefano N, Sormani MP, Pelletier D, Lebrun C.

PLoS One. 2014;9 (3) :e90509. Epub 2014 Mar 5. PMID: 24598783

8.

Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis?

Burns MN, Nawacki E, Kwasny MJ, Pelletier D, Mohr DC.

Psychol Med. 2014 Jan;44 (2) :349-59. Epub 2013 May 17. PMID: 23680407

9.

Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study.

Chitnis T, Guttmann CR, Zaitsev A, Musallam A, Weinstock-Guttmann B, Yeh A, Rodriguez M, Ness J, Gorman M, Healy BC, Kuntz N, Chabas D, Strober JB, Waubant E, Krupp L, Pelletier D, Erickson B, Bergsland N, Zivadinov R.

BMC Neurol. 2013 Nov 13;13 (1) :173. Epub 2013 Nov 13. PMID: 24225378

10.

Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls.

Nickles D, Chen HP, Li MM, Khankhanian P, Madireddy L, Caillier SJ, Santaniello A, Cree BA, Pelletier D, Hauser SL, Oksenberg JR, Baranzini SE.

Hum Mol Genet. 2013 Oct 15;22 (20) :4194-205. Epub 2013 Jun 6. PMID: 23748426

11.

The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [¹¹C]PBR28 PET study.

Hannestad J, DellaGioia N, Gallezot JD, Lim K, Nabulsi N, Esterlis I, Pittman B, Lee JY, O'Connor KC, Pelletier D, Carson RE.

Brain Behav Immun. 2013 Oct;33 :131-8. Epub 2013 Jul 9. PMID: 23850810

12.

A genome-wide association study of brain lesion distribution in multiple sclerosis.

Gourraud PA, Sdika M, Khankhanian P, Henry RG, Beheshtian A, Matthews PM, Hauser SL, Oksenberg JR, Pelletier D, Baranzini SE.

Brain. 2013 Apr;136 (Pt 4) :1012-24. Epub 2013 Feb 13. PMID: 23412934

13.

The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects.

Minagar A, Barnett MH, Benedict RH, Pelletier D, Pirko I, Sahraian MA, Frohman E, Zivadinov R.

Neurology. 2013 Jan 8;80 (2) :210-9. PMID: 23296131

14.

A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis.

Bian W, Harter K, Hammond-Rosenbluth KE, Lupo JM, Xu D, Kelley DA, Vigneron DB, Nelson SJ, Pelletier D.

Mult Scler. 2013 Jan;19 (1) :69-75. Epub 2012 May 28. PMID: 22641301

15.

Prospective examination of anxiety and depression before and during confirmed and pseudoexacerbations in patients with multiple sclerosis.

Burns MN, Nawacki E, Siddique J, Pelletier D, Mohr DC.

Psychosom Med. 2013 Jan;75 (1) :76-82. Epub 2012 Nov 28. PMID: 23197840

16.

Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.

Yousry TA, Pelletier D, Cadavid D, Gass A, Richert ND, Radue EW, Filippi M.

Ann Neurol. 2012 Nov;72 (5) :779-87. PMID: 23280794

17.

Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort.

Lebrun C, Le Page E, Kantarci O, Siva A, Pelletier D, Okuda DT.

Mult Scler. 2012 Sep;18 (9) :1297-302. Epub 2012 Feb 2. PMID: 22300971

18.

Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.

Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR, Gourraud PA, Brenneman D, Owen MC, Qualley P, Bucci M, Hauser SL, Pelletier D.

Ann Neurol. 2012 Aug;72 (2) :234-40. PMID: 22926855

19.

A randomized trial of stress management for the prevention of new brain lesions in MS.

Mohr DC, Lovera J, Brown T, Cohen B, Neylan T, Henry R, Siddique J, Jin L, Daikh D, Pelletier D.

Neurology. 2012 Jul 31;79 (5) :412-9. Epub 2012 Jul 11. PMID: 22786596

20.

Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study.

Waubant E, Pelletier D, Mass M, Cohen JA, Kita M, Cross A, Bar-Or A, Vollmer T, Racke M, Stüve O, Schwid S, Goodman A, Kachuck N, Preiningerova J, Weinstock-Guttman B, Calabresi PA, Miller A, Mokhtarani M, Iklé D, Murphy S, Kopetskie H, Ding L, Rosenberg E, Spencer C, Zamvil SS.

Neurology. 2012 Apr 10;78 (15) :1171-8. Epub 2012 Mar 28. PMID: 22459680

21.

Association between pathological and MRI findings in multiple sclerosis.

Filippi M, Rocca MA, Barkhof F, Brück W, Chen JT, Comi G, DeLuca G, De Stefano N, Erickson BJ, Evangelou N, Fazekas F, Geurts JJ, Lucchinetti C, Miller DH, Pelletier D, Popescu BF, Lassmann H.

Lancet Neurol. 2012 Apr;11 (4) :349-60. Epub 2012 Mar 19. PMID: 22441196

22.

Clinical applications of imaging disease burden in multiple sclerosis: MRI and advanced imaging techniques.

Riley C, Azevedo C, Bailey M, Pelletier D.

Expert Rev Neurother. 2012 Mar;12 (3) :323-33. PMID: 22364331

23.

Fingolimod for multiple sclerosis.

Pelletier D, Hafler DA.

N Engl J Med. 2012 Jan 26;366 (4) :339-47. PMID: 22276823

24.

Monodispersed biocompatible silver sulfide nanoparticles: facile extracellular biosynthesis using the γ-proteobacterium, Shewanella oneidensis.

Suresh AK, Doktycz MJ, Wang W, Moon JW, Gu B, Meyer HM 3rd, Hensley DK, Allison DP, Phelps TJ, Pelletier DA.

Acta Biomater. 2011 Dec;7 (12) :4253-8. Epub 2011 Jul 14. PMID: 21798382

25.

Magnetic resonance techniques in multiple sclerosis: the present and the future.

Filippi M, Rocca MA, De Stefano N, Enzinger C, Fisher E, Horsfield MA, Inglese M, Pelletier D, Comi G.

Arch Neurol. 2011 Dec;68 (12) :1514-20. PMID: 22159052

26.

Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability.

Roosendaal SD, Bendfeldt K, Vrenken H, Polman CH, Borgwardt S, Radue EW, Kappos L, Pelletier D, Hauser SL, Matthews PM, Barkhof F, Geurts JJ.

Mult Scler. 2011 Sep;17 (9) :1098-106. Epub 2011 May 17. PMID: 21586487

27.

Multiple sclerosis and chronic cerebrospinal venous insufficiency: the neuroimaging perspective.

Filippi M, Rocca MA, Barkhof F, Bakshi R, Fazekas F, Khan O, Pelletier D, Rovira A, Simon J.

AJNR Am J Neuroradiol. 2011 Mar;32 (3) :424-7. Epub 2011 Feb 3. PMID: 21292801

28.

Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome.

Okuda DT, Mowry EM, Cree BA, Crabtree EC, Goodin DS, Waubant E, Pelletier D.

Neurology. 2011 Feb 22;76 (8) :686-92. Epub 2011 Jan 26. PMID: 21270417

29.

Switching multiple sclerosis patients with breakthrough disease to second-line therapy.

Castillo-Trivino T, Mowry EM, Gajofatto A, Chabas D, Crabtree-Hartman E, Cree BA, Goodin DS, Green AJ, Okuda DT, Pelletier D, Zamvil SS, Vittinghoff E, Waubant E.

PLoS One. 2011 Feb 3;6 (2) :e16664. Epub 2011 Feb 3. PMID: 21304907

30.

Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data.

Wang JH, Pappas D, De Jager PL, Pelletier D, de Bakker PI, Kappos L, Polman CH, Chibnik LB, Hafler DA, Matthews PM, Hauser SL, Baranzini SE, Oksenberg JR.

Genome Med. 2011 Jan 18;3 (1) :3. Epub 2011 Jan 18. PMID: 21244703

31.

Conformal metric optimization on surface (CMOS) for deformation and mapping in Laplace-Beltrami embedding space.

Shi Y, Lai R, Gill R, Pelletier D, Mohr D, Sicotte N, Toga AW.

Med Image Comput Comput Assist Interv. 2011;14 (Pt 2) :327-34. PMID: 21995045

32.

Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis.

Baranzini SE, Srinivasan R, Khankhanian P, Okuda DT, Nelson SJ, Matthews PM, Hauser SL, Oksenberg JR, Pelletier D.

Brain. 2010 Sep;133 (9) :2603-11. PMID: 20802204

33.

High-resolution phased-array MRI of the human brain at 7 tesla: initial experience in multiple sclerosis patients.

Metcalf M, Xu D, Okuda DT, Carvajal L, Srinivasan R, Kelley DA, Mukherjee P, Nelson SJ, Vigneron DB, Pelletier D.

J Neuroimaging. 2010 Apr;20 (2) :141-7. Epub 2009 Jan 29. PMID: 19187478

34.

MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis.

Srinivasan R, Ratiney H, Hammond-Rosenbluth KE, Pelletier D, Nelson SJ.

Magn Reson Imaging. 2010 Feb;28 (2) :163-70. Epub 2009 Aug 19. PMID: 19695821

35.

An in vivo imaging-based assay for detecting protein interactions over a wide range of binding affinities.

Edwards AN, Fowlkes JD, Owens ET, Standaert RF, Pelletier DA, Hurst GB, Doktycz MJ, Morrell-Falvey JL.

Anal Biochem. 2009 Dec 15;395 (2) :166-77. Epub 2009 Aug 19. PMID: 19698693

36.

Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults.

Waubant E, Chabas D, Okuda DT, Glenn O, Mowry E, Henry RG, Strober JB, Soares B, Wintermark M, Pelletier D.

Arch Neurol. 2009 Aug;66 (8) :967-71. PMID: 19667217

37.

Connecting white matter injury and thalamic atrophy in clinically isolated syndromes.

Henry RG, Shieh M, Amirbekian B, Chung S, Okuda DT, Pelletier D.

J Neurol Sci. 2009 Jul 15;282 (1-2) :61-6. Epub 2009 Apr 23. PMID: 19394969

38.

Pathway and network-based analysis of genome-wide association studies in multiple sclerosis.

Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, Pelletier D, Wu W, Uitdehaag BM, Kappos L, Polman CH, Matthews PM, Hauser SL, Gibson RA, Oksenberg JR, Barnes MR.

Hum Mol Genet. 2009 Jun 1;18 (11) :2078-90. Epub 2009 Mar 13. PMID: 19286671

39.

Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures.

Mowry EM, Beheshtian A, Waubant E, Goodin DS, Cree BA, Qualley P, Lincoln R, George MF, Gomez R, Hauser SL, Okuda DT, Pelletier D.

Neurology. 2009 May 19;72 (20) :1760-5. PMID: 19451531

40.

41.

Sorting through the pediatric MS spectrum with brain MRI.

Chabas D, Pelletier D.

Nat Rev Neurol. 2009 Apr;5 (4) :186-8. PMID: 19347023

42.

Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome.

Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, Hauser SL, Pelletier D.

Neurology. 2009 Mar 3;72 (9) :800-5. Epub 2008 Dec 10. PMID: 19073949

43.

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis.

Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, Radue EW, Lindberg RL, Uitdehaag BM, Johnson MR, Angelakopoulou A, Hall L, Richardson JC, Prinjha RK, Gass A, Geurts JJ, Kragt J, Sombekke M, Vrenken H, Qualley P, Lincoln RR, Gomez R, Caillier SJ, George MF, Mousavi H, Guerrero R, Okuda DT, Cree BA, Green AJ, Waubant E, Goodin DS, Pelletier D, Matthews PM, Hauser SL, Kappos L, Polman CH, Oksenberg JR.

Hum Mol Genet. 2009 Feb 15;18 (4) :767-78. Epub 2008 Nov 14. PMID: 19010793

44.

Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures.

Okuda DT, Srinivasan R, Oksenberg JR, Goodin DS, Baranzini SE, Beheshtian A, Waubant E, Zamvil SS, Leppert D, Qualley P, Lincoln R, Gomez R, Caillier S, George M, Wang J, Nelson SJ, Cree BA, Hauser SL, Pelletier D.

Brain. 2009 Jan;132 (Pt 1) :250-9. Epub 2008 Nov 20. PMID: 19022862

45.

Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron.

Hammond KE, Metcalf M, Carvajal L, Okuda DT, Srinivasan R, Vigneron D, Nelson SJ, Pelletier D.

Ann Neurol. 2008 Dec;64 (6) :707-13. PMID: 19107998

46.

Regional grey matter atrophy in clinically isolated syndromes at presentation.

Henry RG, Shieh M, Okuda DT, Evangelista A, Gorno-Tempini ML, Pelletier D.

J Neurol Neurosurg Psychiatry. 2008 Nov;79 (11) :1236-44. Epub 2008 May 9. PMID: 18469033

47.

Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event.

Corvol JC, Pelletier D, Henry RG, Caillier SJ, Wang J, Pappas D, Casazza S, Okuda DT, Hauser SL, Oksenberg JR, Baranzini SE.

Proc Natl Acad Sci U S A. 2008 Aug 19;105 (33) :11839-44. Epub 2008 Aug 8. PMID: 18689680

48.

MRI in multiple sclerosis: current status and future prospects.

Bakshi R, Thompson AJ, Rocca MA, Pelletier D, Dousset V, Barkhof F, Inglese M, Guttmann CR, Horsfield MA, Filippi M.

Lancet Neurol. 2008 Jul;7 (7) :615-25. PMID: 18565455

49.

Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases.

Hammond KE, Lupo JM, Xu D, Metcalf M, Kelley DA, Pelletier D, Chang SM, Mukherjee P, Vigneron DB, Nelson SJ.

Neuroimage. 2008 Feb 15;39 (4) :1682-92. Epub 2007 Nov 7. PMID: 18096412

50.

Whole brain voxel-wise analysis of single-subject serial DTI by permutation testing.

Chung S, Pelletier D, Sdika M, Lu Y, Berman JI, Henry RG.

Neuroimage. 2008 Feb 15;39 (4) :1693-705. Epub 2007 Nov 7. PMID: 18082426

51.

Estimation of metabolite T1 relaxation times using tissue specific analysis, signal averaging and bootstrapping from magnetic resonance spectroscopic imaging data.

Ratiney H, Noworolski SM, Sdika M, Srinivasan R, Henry RG, Nelson SJ, Pelletier D.

MAGMA. 2007 Jun;20 (3) :143-55. Epub 2007 Jun 30. PMID: 17602253

52.

Multislice brain myelin water fractions at 3T in multiple sclerosis.

Oh J, Han ET, Lee MC, Nelson SJ, Pelletier D.

J Neuroimaging. 2007 Apr;17 (2) :156-63. PMID: 17441837

53.

TE-averaged two-dimensional proton spectroscopic imaging of glutamate at 3 T.

Srinivasan R, Cunningham C, Chen A, Vigneron D, Hurd R, Nelson S, Pelletier D.

Neuroimage. 2006 May 1;30 (4) :1171-8. Epub 2006 Jan 23. PMID: 16431138

55.

Measurement of in vivo multi-component T2 relaxation times for brain tissue using multi-slice T2 prep at 1.5 and 3 T.

Oh J, Han ET, Pelletier D, Nelson SJ.

Magn Reson Imaging. 2006 Jan;24 (1) :33-43. Epub 2005 Dec 19. PMID: 16410176

56.

Toxic brainstem encephalopathy after artemisinin treatment for breast cancer.

Panossian LA, Garga NI, Pelletier D.

Ann Neurol. 2005 Nov;58 (5) :812-3. PMID: 16240360

57.

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab.

Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D.

N Engl J Med. 2005 Jul 28;353 (4) :375-81. Epub 2005 Jun 9. PMID: 15947078

58.

Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.

Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D.

Brain. 2005 May;128 (Pt 5) :1016-25. Epub 2005 Mar 9. PMID: 15758036

59.

The unique impact of changes in normal appearing brain tissue on cognitive dysfunction in secondary progressive multiple sclerosis patients.

Cox D, Pelletier D, Genain C, Majumdar S, Lu Y, Nelson S, Mohr DC.

Mult Scler. 2004 Dec;10 (6) :626-9. PMID: 15584486

60.

Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging.

Oh J, Henry RG, Genain C, Nelson SJ, Pelletier D.

J Neurol Neurosurg Psychiatry. 2004 Sep;75 (9) :1281-6. PMID: 15314115

61.

Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.

Oh J, Pelletier D, Nelson SJ.

Arch Neurol. 2004 Jul;61 (7) :1081-6. PMID: 15262739

62.

Measurement of whole-brain atrophy in multiple sclerosis.

Pelletier D, Garrison K, Henry R.

J Neuroimaging. 2004 Jul;14 (3 Suppl) :11S-19S. PMID: 15228755

63.

Mitoxantrone as a potential therapy for primary progressive multiple sclerosis.

Stüve O, Kita M, Pelletier D, Fox RJ, Stone J, Goodkin DE, Zamvil SS.

Mult Scler. 2004 Jun;10 Suppl 1 :S58-61. PMID: 15218811

64.

Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis.

Mohr DC, Hart SL, Julian L, Cox D, Pelletier D.

BMJ. 2004 Mar 27;328 (7442) :731. Epub 2004 Mar 19. PMID: 15033880

65.

Directional diffusion in relapsing-remitting multiple sclerosis: a possible in vivo signature of Wallerian degeneration.

Henry RG, Oh J, Nelson SJ, Pelletier D.

J Magn Reson Imaging. 2003 Oct;18 (4) :420-6. PMID: 14508778

66.

AFM imaging of bacteria in liquid media immobilized on gelatin coated mica surfaces.

Doktycz MJ, Sullivan CJ, Hoyt PR, Pelletier DA, Wu S, Allison DP.

Ultramicroscopy. 2003 Oct-Nov;97 (1-4) :209-16. PMID: 12801673

67.

MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy.

Pelletier D, Nelson SJ, Oh J, Antel JP, Kita M, Zamvil SS, Goodkin DE.

J Neurol Neurosurg Psychiatry. 2003 Jul;74 (7) :950-2. PMID: 12810788

68.

HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course.

Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E, Goodin DS, Pelletier D, Lincoln RR, Bucher P, Swerdlin A, Pericak-Vance MA, Haines JL, Hauser SL.

Am J Hum Genet. 2003 Mar;72 (3) :710-6. Epub 2003 Jan 28. PMID: 12557126

69.

Standardized, reproducible, high resolution global measurements of T1 relaxation metrics in cases of multiple sclerosis.

Srinivasan R, Henry R, Pelletier D, Nelson S.

AJNR Am J Neuroradiol. 2003 Jan;24 (1) :58-67. PMID: 12533328

70.

T2 relaxation time histograms in multiple sclerosis.

Grenier D, Pelletier D, Normandeau M, Newitt D, Nelson S, Goodkin DE, Majumdar S.

Magn Reson Imaging. 2002 Dec;20 (10) :733-41. PMID: 12591569

71.

Dissociating perceptual and conceptual implicit memory in multiple sclerosis patients.

Blum D, Yonelinas AP, Luks T, Newitt D, Oh J, Lu Y, Nelson S, Goodkin D, Pelletier D.

Brain Cogn. 2002 Oct;50 (1) :51-61. PMID: 12372351

72.

3-D echo planar (1)HMRS imaging in MS: metabolite comparison from supratentorial vs. central brain.

Pelletier D, Nelson SJ, Grenier D, Lu Y, Genain C, Goodkin DE.

Magn Reson Imaging. 2002 Oct;20 (8) :599-606. PMID: 12467867

73.

Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.

Narayanan S, De Stefano N, Francis GS, Arnaoutelis R, Caramanos Z, Collins DL, Pelletier D, Arnason BGW, Antel JP, Arnold DL.

J Neurol. 2001 Nov;248 (11) :979-86. PMID: 11757963

74.

Seeding information management capacity to support operational management in hospitals.

Diers D, Pelletier D.

Aust Health Rev. 2001;24 (2) :74-82. PMID: 11496476

75.

Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images.

Pike GB, De Stefano N, Narayanan S, Worsley KJ, Pelletier D, Francis GS, Antel JP, Arnold DL.

Radiology. 2000 Jun;215 (3) :824-30. PMID: 10831705

76.

Heterogeneity of T-lymphocyte function in primary progressive multiple sclerosis: relation to magnetic resonance imaging lesion volume.

Prat A, Pelletier D, Duquette P, Arnold DL, Antel JP.

Ann Neurol. 2000 Feb;47 (2) :234-7. PMID: 10665495

77.

Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy.

Becher B, Giacomini PS, Pelletier D, McCrea E, Prat A, Antel JP.

Ann Neurol. 1999 Feb;45 (2) :247-50. PMID: 9989628

78.

111Indium-labelled lymphocytes do not image or label the pancreas of the BB/W rat.

Gallina DL, Pelletier D, Doherty P, Koevary SB, Williams RM, Like AA, Chick WL, Rossini AA.

Diabetologia. 1985 Mar;28 (3) :143-7. PMID: 3996795